Allergan (NYSE: AGN) announced the launch of the over-the-counter artificial tear REFRESH OPTIVE® Gel Drops, a new aqueous gel expertly ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Comments

Allergan Expands Dry Eye Portfolio With Launch Of REFRESH OPTIVE® Gel DropsOctober 21, 2015 8:01 AM Wall Street hit by healthcare slump; U.S. yields rise October 19, 2015 8:05 PM